Artigos de revistas sobre o tema "RSA advisors/referents"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "RSA advisors/referents".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Carande, Robert. "Reference Advisory Systems (RAS): Some Practical Issues". Reference Services Review 17, n.º 3 (março de 1989): 87–90. http://dx.doi.org/10.1108/eb049069.
Texto completo da fonteAmbrogi, Federica. "Elisa Paini (1863-1924). Wife and «unbeatable collaborator» of Luigi Credaro". Rivista di Storia dell’Educazione 7, n.º 2 (4 de dezembro de 2020): 133–44. http://dx.doi.org/10.36253/rse-9865.
Texto completo da fonteWalker, Christopher J., Junke Wang, Alyssa I. Clay-Gilmour, Krzysztof Mrózek, Deedra Nicolet, Christopher C. Oakes, Jessica Kohlschmidt et al. "Meta-Analysis of Genome-Wide Association Studies of Acute Myeloid Leukemia (AML) Patients Identifies Variants Associated with Risk of 11q23/KMT2A-Translocated and Core-Binding Factor (CBF) AML and Suggests a Role for Transcription Elongation in Leukemogenesis". Blood 136, Supplement 1 (5 de novembro de 2020): 29–30. http://dx.doi.org/10.1182/blood-2020-141653.
Texto completo da fonteVisconte, Valeria, Bartlomiej P. Przychodzen, Vera Adema, Cassandra M. Hirsch, Allison Noe, Rachel Toth, Christina Snider et al. "Development of a Novel Class of Agents Targeting the RNA-Splicing Machinery in Myeloid Malignancies". Blood 132, Supplement 1 (29 de novembro de 2018): 211. http://dx.doi.org/10.1182/blood-2018-99-116411.
Texto completo da fonteYalniz, Fevzi F., Rima M. Saliba, Orhan K. Yucel, Guillermo Garcia-Manero, Jeremy Ramdial, Uday Popat, Stefan O. Ciurea et al. "Somatic Mutations Improve Risk Classification By Cytogenetic Abnormalities in Patients with Myelodysplastic Syndrome after Hematopoietic Stem Cell Transplantation". Blood 134, Supplement_1 (13 de novembro de 2019): 512. http://dx.doi.org/10.1182/blood-2019-125937.
Texto completo da fonteMurphy, Tracy, Stanley W. K. Ng, Tong Zhang, Ian King, Andrea Arruda, Jaime O. Claudio, Narmin Ibrahimova et al. "Trial in Progress: Feasibility and Validation Study of the LSC17 Score in Acute Myeloid Leukemia Patients". Blood 134, Supplement_1 (13 de novembro de 2019): 2682. http://dx.doi.org/10.1182/blood-2019-130532.
Texto completo da fonteMahevas, Matthieu, Stephanie Guillet, Jean-Francois Viallard, Delphine Gobert, Marion Malphettes, Stephane Cheze, Francois Lefrere et al. "Rate of Prolonged Response after Stopping Thrombopoietin-Receptor Agonists Treatment in Primary Immune Thrombocytopenia (ITP): Results from a Nationwide Prospective Multicenter Interventional Study (STOPAGO)". Blood 138, Supplement 1 (5 de novembro de 2021): 583. http://dx.doi.org/10.1182/blood-2021-152767.
Texto completo da fonteTomaz, Victória, Karina Griesi-Oliveira, Renato D. Puga, Fabio Pires de Souza Santos, Nelson Hamerschlak e Paulo Vidal Campregher. "Identification of Gene Networks Associated with the Anti-Leukemic Effect of Anti-Inflammatory Drugs on Acute Myeloid Leukemia Cell Lines". Blood 138, Supplement 1 (5 de novembro de 2021): 4343. http://dx.doi.org/10.1182/blood-2021-153903.
Texto completo da fontePerumal, Deepak, Alessandro Lagana', Alex Rubinsteyn, John P. Finnigan, Pei-Yu Kuo, Violetta V. Leshchenko, Ajai Chari et al. "Patient-Specific Mutation-Derived Tumor Antigens As Targets for Cancer Immunotherapy in Multiple Myeloma". Blood 126, n.º 23 (3 de dezembro de 2015): 1851. http://dx.doi.org/10.1182/blood.v126.23.1851.1851.
Texto completo da fonteYao, Lijun, Reyka G. Jayasinghe, Beena E. Thomas, Swati S. Bhasin, Nicolas Fernandez, Taxiarchis Kourelis, Deon Doxie et al. "Integrated Cytof, Scrna-Seq and Cite-Seq Analysis of Bone Marrow Immune Microenvironment in the Mmrf Commpass Study". Blood 136, Supplement 1 (5 de novembro de 2020): 28–29. http://dx.doi.org/10.1182/blood-2020-142534.
Texto completo da fontePelham, Robert J., Xuguang Hu, Philippe Moreau, Albert Oriol, Hang Quach, Tibor Kovacsovics, Jonathan J. Keats, Shibao Feng, Amy S. Kimball e Meletios A. Dimopoulos. "Genomic Predictors of Progression-Free Survival Among Patients with Relapsed or Refractory Multiple Myeloma Treated with Carfilzomib and Dexamethasone or Bortezomib and Dexamethasone in the Phase 3 Endeavor Trial". Blood 130, Suppl_1 (7 de dezembro de 2017): 839. http://dx.doi.org/10.1182/blood.v130.suppl_1.839.839.
Texto completo da fonteMageau, Arthur, Louis Terriou, Mikael Ebbo, Odile Souchaud-Debouverie, Corentin Orvain, Julie Graveleau, Jean-Christophe Lega et al. "Splenectomy for Primary Immune Thrombocytopenia Revisited at the Era of Thrombopoietin Receptor Agonists: New Insights for an Old Treatment". Blood 138, Supplement 1 (5 de novembro de 2021): 17. http://dx.doi.org/10.1182/blood-2021-147450.
Texto completo da fonteBrummaier, Tobias, Basirudeen Syed Ahamed Kabeer, Stephen Lindow, Justin C. Konje, Sasithon Pukrittayaamee, Juerg Utzinger, Mohammed Toufiq et al. "A prospective cohort for the investigation of alteration in temporal transcriptional and microbiome trajectories preceding preterm birth: a study protocol". BMJ Open 9, n.º 1 (janeiro de 2019): e023417. http://dx.doi.org/10.1136/bmjopen-2018-023417.
Texto completo da fonteCroucher, Danielle C., Marta Chesi, Zhihua Li, Victoria Marie Garbitt, Meaghen E. Sharik, Daniel Waller, Michael Sebag, P. Leif Bergsagel, Trevor J. Pugh e Suzanne Trudel. "A Single-Cell Transcriptional Analysis of Tumour Cells and the Immune Microenvironment during Disease Evolution in a Transgenic Mouse Model of Myeloma". Blood 132, Supplement 1 (29 de novembro de 2018): 56. http://dx.doi.org/10.1182/blood-2018-99-118691.
Texto completo da fonteNicolini, Franck E., Vincent Alcazer, Stephanie Dulucq, Sandrine Hayette, Jean-Michel Cayuela, Stephane Morisset, Christophe Bouvier, Francois-Xavier Mahon, Gabriel Etienne e Delphine Rea. "The Outcome of Treatment-Free Remission after First-Line Nilotinib or Dasatinib in Chronic Phase Chronic Myeloid Leukemia Patients Is Different". Blood 138, Supplement 1 (5 de novembro de 2021): 2552. http://dx.doi.org/10.1182/blood-2021-146722.
Texto completo da fonteRoeser, Anais, Guillaume Moulis, Mikael Ebbo, Louis Terriou, Elsa Poullot, Bertrand Lioger, Marie Chilles et al. "A Retrospective Multicenter Case Study Evaluating the Characteristics, Management and Outcome of Acquired Amegakaryocytic Thrombocytopenia". Blood 138, Supplement 1 (5 de novembro de 2021): 3167. http://dx.doi.org/10.1182/blood-2021-153388.
Texto completo da fonteBloehdorn, Johannes, Julia Krzykalla, Billy Michael Chelliah Jebaraj, Karlheinz Holzmann, Jasmin Bahlo, Sandra Robrecht, Kathryn Humphrey et al. "MYC Pathway Activation Is Frequently Observed in Treatment-Naive CLL and Defines a Subgroup with Particular Benefit from the Addition of Rituximab to Chemotherapy". Blood 132, Supplement 1 (29 de novembro de 2018): 1866. http://dx.doi.org/10.1182/blood-2018-99-116937.
Texto completo da fonteFulciniti, Mariateresa, Charles Y. Lin, Mehmet K. Samur, Matthew Lawlor, Kenneth C. Anderson, James E. Bradner e Nikhil C. Munshi. "Discovery and Characterization of Promoter and Super-Enhancer-Associated Dependencies through E2F and BET Bromodomains in Multiple Myeloma". Blood 126, n.º 23 (3 de dezembro de 2015): 838. http://dx.doi.org/10.1182/blood.v126.23.838.838.
Texto completo da fontevan Beers, Erik H., Martin H. Van Vliet, Kenneth C. Anderson, Ajai Chari, Sundar Jagannath, Andrzej Jakubowiak, Shaji K. Kumar et al. "High Risk Multiple Myeloma Cases Are Identified In An MMRC Led Study By The SKY92 Gene Signature (MMprofiler)". Blood 122, n.º 21 (15 de novembro de 2013): 1854. http://dx.doi.org/10.1182/blood.v122.21.1854.1854.
Texto completo da fonteAsmann, Yan, Ying Li, Taxiarchis Kourelis, Moritz Binder, Wilson I. Gonsalves, Henan Zhang, Anatilde Gonzalez Guerrico et al. "Single Cell Transcriptome Profile of Myeloma and Immune Cell Characteristics in Patients with Durable Response Post CART". Blood 138, Supplement 1 (5 de novembro de 2021): 3838. http://dx.doi.org/10.1182/blood-2021-153254.
Texto completo da fonteMurphy, Tracy, Stanley W. K. Ng, Ian King, Tong Zhang, Andrea Arruda, Narmin Ibrahimova, Jaime O. Claudio et al. "Inferior Outcomes with a High LSC17 Score Can be Improved with Flag-IDA". Blood 136, Supplement 1 (5 de novembro de 2020): 35–36. http://dx.doi.org/10.1182/blood-2020-138943.
Texto completo da fonteCatalano, Calogerina, Joanna Blocka, Stefanie Huhn, Nagarajan Paramasivam, Matthias Schlesner, Niels Weinhold, Rolf Sijmons et al. "Characterization of Rare Germline Variants in Familial Multiple Myeloma". Blood 136, Supplement 1 (5 de novembro de 2020): 45–46. http://dx.doi.org/10.1182/blood-2020-142253.
Texto completo da fonteTirier, Stephan M., Jan-Philipp Mallm, Nicola Casiraghi, Hana Susak, Nicola Giesen, Alexandra M. Poos, Katharina Bauer et al. "Dissecting Heterogeneity of Tumor Cells and Their Microenvironment in Refractory Multiple Myeloma". Blood 134, Supplement_1 (13 de novembro de 2019): 571. http://dx.doi.org/10.1182/blood-2019-128625.
Texto completo da fonteMaeding, Nicole, Daniela Asslaber, Nadja Zaborsky, Andreas Villunger, Richard Greil e Alexander Egle. "Lack of Bmf Facilitates the Selection of Highly Responsive B-Cell Receptor Clones in Chronic Lymphocytic Leukemia". Blood 138, Supplement 1 (5 de novembro de 2021): 1543. http://dx.doi.org/10.1182/blood-2021-152216.
Texto completo da fonteGarg, Tarun K., Ricky D. Edmondson, Shweta S. Chavan, Katie Stone, Justin M. Stivers, Jessica I. Warden, Veronica Macleod et al. "Differential ICAM3 Gene Expression Correlates with Susceptibility to Natural Killer Cell-Mediated Lysis in Multiple Myeloma". Blood 126, n.º 23 (3 de dezembro de 2015): 2990. http://dx.doi.org/10.1182/blood.v126.23.2990.2990.
Texto completo da fonteMehr, Shaadi, Daniel Auclair, Mark Hamilton, Leon Rozenblit, Hearn Jay Cho, Lijun Yao, Reyka G. Jayasinghe et al. "Architecture of Sample Preparation and Data Governance of Immuno-Genomic Data Collected from Bone Marrow and Peripheral Blood Samples Obtained from Multiple Myeloma Patients". Blood 136, Supplement 1 (5 de novembro de 2020): 17–18. http://dx.doi.org/10.1182/blood-2020-142882.
Texto completo da fonteTarantino, Michael D., Michael Vredenburg, Wei Tian, Brian Jamieson e Kashyap B. Patel. "Efficacy Analyses from the Immune Thrombocytopenia (ITP) Clinical Development Program for Avatrombopag: Comparisons with Placebo and Eltrombopag". Blood 136, Supplement 1 (5 de novembro de 2020): 23–24. http://dx.doi.org/10.1182/blood-2020-142788.
Texto completo da fonteWhite, Brian S., Suleiman A. Khan, Muhammad Ammad-ud-din, Swapnil Potdar, Mike J. Mason, Cristina E. Tognon, Brian J. Druker et al. "Comparative Analysis of Independent Ex Vivo functional Drug Screens Identifies Predictive Biomarkers of BCL-2 Inhibitor Response in AML". Blood 132, Supplement 1 (29 de novembro de 2018): 2763. http://dx.doi.org/10.1182/blood-2018-99-111916.
Texto completo da fonteMishima, Yuji, Michele Moschetta, Jiantao Shi, Francois Mercier, Salomon Manier, Siobhan Glavey, Michaela R. Reagan et al. "Clonal-Heterogeneity and Propensity for Bone Metastasis in Multiple Myeloma". Blood 124, n.º 21 (6 de dezembro de 2014): 3370. http://dx.doi.org/10.1182/blood.v124.21.3370.3370.
Texto completo da fonteWang, Tianjiao, Hua Sun, Daniel Cui Zhou, Ruiyang Liu, Lijun Yao, Mark A. Fiala, Daniel R. Kohnen et al. "Single-Cell Pathway Enrichment and Regulatory Profiling of Multiple Myeloma across Disease Stages". Blood 134, Supplement_1 (13 de novembro de 2019): 364. http://dx.doi.org/10.1182/blood-2019-131361.
Texto completo da fonteSpencer, Andrew, Tiffany Khong e Maoshan Chenn. "MCL-1 Inhibitor-Induced Killing of Multiple Myeloma Is Modulated By the Relative Level of Expression of Pro-Survival Members of the BCL-2 Family and the Proto-Oncogene MYC". Blood 134, Supplement_1 (13 de novembro de 2019): 1825. http://dx.doi.org/10.1182/blood-2019-127843.
Texto completo da fonteMatino, Davide, Giancarlo Castaman, Giovanni Di Minno, Paola Giordano, Maria Elisa Mancuso, Emanuela Marchesini, Flora Peyvandi et al. "Prospective Study of the Immunological Mechanisms of Immune Tolerance Induction in Severe Haemophilia a Patients with Inhibitors: Preliminary Analysis of a Multi-Center Longitudinal Study". Blood 132, Supplement 1 (29 de novembro de 2018): 3781. http://dx.doi.org/10.1182/blood-2018-99-119568.
Texto completo da fonteWallace, Sarah, Victoria Hall, Andre Charlett, Peter D. Kirwan, Michele Cole, Natalie Gillson, Ana Atti et al. "Impact of prior SARS-CoV-2 infection and COVID-19 vaccination on the subsequent incidence of COVID-19: a multicentre prospective cohort study among UK healthcare workers – the SIREN (Sarscov2 Immunity & REinfection EvaluatioN) study protocol". BMJ Open 12, n.º 6 (junho de 2022): e054336. http://dx.doi.org/10.1136/bmjopen-2021-054336.
Texto completo da fonteLee, Shawn, Federico Antillón, Deqing Pei, Wenjian Yang, Kathryn G. Roberts, Zhenhua Li, Meenakshi Devidas et al. "The Impact of Genetic Ancestry on the Biology and Prognosis of Childhood Acute Lymphoblastic Leukemia". Blood 138, Supplement 1 (5 de novembro de 2021): 3476. http://dx.doi.org/10.1182/blood-2021-145655.
Texto completo da fonteSauer, Sandra, Christos Sachpekidis, Simone Brandelik, Daniel Spira, Stefanie Huhn, Barbara Wagner, Manuela Hummel et al. "Prospective Evaluation of 18-F FDG PET/CT and Biopsies of Osteolytic Lesions and Random Bone Marrow Samples in Newly Diagnosed Multiple Myeloma Patients". Blood 132, Supplement 1 (29 de novembro de 2018): 3180. http://dx.doi.org/10.1182/blood-2018-99-115201.
Texto completo da fonteRoter, Kyle, Donglei Hu, Alyssa Clay-Gilmour, Scott Huntsman, Nina D. Shah, Sandy W. Wong, Thomas G. Martin et al. "Germline Variation Predicts Treatment Response in Multiple Myeloma". Blood 134, Supplement_1 (13 de novembro de 2019): 4397. http://dx.doi.org/10.1182/blood-2019-129344.
Texto completo da fontePoos, Alexandra M., Jan-Philipp Mallm, Stephan M. Tirier, Nicola Casiraghi, Hana Susak, Nicola Giesen, Katharina Bauer et al. "A Comprehensive Analysis of Single-Cell Chromatin Accessibility and Gene Expression Identifies Intra-Tumor Heterogeneity and Molecular Treatment Responses in Relapsed/Refractory Multiple Myeloma". Blood 134, Supplement_1 (13 de novembro de 2019): 575. http://dx.doi.org/10.1182/blood-2019-130051.
Texto completo da fonteCoffey, David G., Francesco Maura, Edgar Gonzalez-Kozlova, Javier Diaz-Mejia3, Ping Luo, Yong Zhang, Yuexin Xu et al. "Normalization of the Immune Microenvironment during Lenalidomide Maintenance Is Associated with Sustained MRD Negativity in Patients with Multiple Myeloma". Blood 138, Supplement 1 (5 de novembro de 2021): 329. http://dx.doi.org/10.1182/blood-2021-154506.
Texto completo da fonteSheih, Alyssa, Jonathan L. Golob, Abir Bhattacharyya, Michael C. Wu, Aesha Vakil, Sujatha Srinivasan, Steven A. Pergam, David N. Fredricks e Cameron J. Turtle. "Impact of Intestinal Microbiota on Reconstitution of Mucosal-Associated Invariant T Cells after Allogeneic Hematopoietic Stem Cell Transplantation". Blood 132, Supplement 1 (29 de novembro de 2018): 3393. http://dx.doi.org/10.1182/blood-2018-99-115158.
Texto completo da fonteMcCarthy, John J. "Alan S. Kaye (ed.) (1997). Phonologies of Asia and Africa (including the Caucasus). Technical advisor: Peter T. Daniels. Winona Lake, Indiana: Eisenbrauns. 2 vols. Pp. xxi+1041." Phonology 15, n.º 1 (agosto de 1998): 111–14. http://dx.doi.org/10.1017/s0952675798003509.
Texto completo da fonteArkian, Muhammad Reyzha Noorsyam, M. Subur Drajat e Dadi Ahmadi. "Peran Public Relations dalam Film Hancock". Inter Komunika : Jurnal Komunikasi 3, n.º 2 (11 de dezembro de 2018): 145. http://dx.doi.org/10.33376/ik.v3i2.214.
Texto completo da fonteDecroocq, Justine, Rudy Birsen, Jordi Mano, Guillemette Fouquet, Mathilde Gotanègre, Laury Poulain, Sarah Mouche et al. "Combination of the MEK Inhibitor Trametinib and Pyrvinium Pamoate Efficiently Targets RAS Pathway-Mutated Acute Myeloid Leukemia in Preclinical Models". Blood 134, Supplement_1 (13 de novembro de 2019): 2671. http://dx.doi.org/10.1182/blood-2019-123418.
Texto completo da fonteZhang, Haiyu, Bing Zhang, Xiangqian Guo, Naznin Haq, Robert B. West, James B. Bussel e James L. Zehnder. "Effects of Thrombopoietin Mimetics on Patients with Chronic ITP: Perspectives from Blood Transcriptome Profiling Analysis". Blood 124, n.º 21 (6 de dezembro de 2014): 2780. http://dx.doi.org/10.1182/blood.v124.21.2780.2780.
Texto completo da fonteBai, Xiaoying, Jennifer Trowbridge, Joseph Lee, Stuart H. Orkin e Leonard I. Zon. "Analysis of TIF1gamma Conditional Knockout Establishes a Requirement for the Differentiation of Multiple Hematopoietic Lineages". Blood 116, n.º 21 (19 de novembro de 2010): 744. http://dx.doi.org/10.1182/blood.v116.21.744.744.
Texto completo da fonteSharma, Priyanka, Sujan Piya, Huaxian Ma, Natalia Baran, Malgorzata Anna Zal, Christopher J. Hindley, Kim-Hien Dao et al. "ERK1/2 Inhibition Overcomes Resistance in Acute Myeloid Leukemia (AML) and Alters Mitochondrial Dynamics". Blood 138, Supplement 1 (5 de novembro de 2021): 3338. http://dx.doi.org/10.1182/blood-2021-151579.
Texto completo da fonteStahlberg, Eric, Lynn Borkon, Ruth Frost, Sara Jones, Amar Khalsa, Lauren Lewis, Emily Greenspan e Sunita Menon. "Abstract 7432: Improving FAIRness of computational approaches for cancer: The computational resources for cancer research portal". Cancer Research 84, n.º 6_Supplement (22 de março de 2024): 7432. http://dx.doi.org/10.1158/1538-7445.am2024-7432.
Texto completo da fonteKumar, Ashwini, Muntasir Mamun Majumder, Jesus María Lopez Martí, Alun Parsons, Pirkko Mattila, Kimmo Porkka, Olli Kallioniemi e Caroline A. Heckman. "The Use of RNA Sequencing to Identify Disease-Specific Gene Expression Signatures and Critical Regulatory Networks Across Hematologic Malignancies". Blood 124, n.º 21 (6 de dezembro de 2014): 2203. http://dx.doi.org/10.1182/blood.v124.21.2203.2203.
Texto completo da fonteChen, Zhenghao, Gaspard Cretenet, Beatriz Valle-Argos, Francesco Forconi, Arnon P. Kater, Graham Packham e Eric Eldering. "Effects of Ibrutinib on Metabolic Alterations and Micro-Environmental Signalling in Chronic Lymphocytic Leukaemia". Blood 136, Supplement 1 (5 de novembro de 2020): 36–37. http://dx.doi.org/10.1182/blood-2020-142839.
Texto completo da fonteClarke, Stanley R., Adrianna Vlachos, Jens Lichtenberg, Nancy E. Seidel, Jaya Jagadeesh, NISC Comparative SequencingProgram, Adam M. Phillippy et al. "Whole Genome Sequencing of Diamond Blackfan Anemia Syndrome Patients Detects Mutations That Alter mRNA Splicing". Blood 138, Supplement 1 (5 de novembro de 2021): 863. http://dx.doi.org/10.1182/blood-2021-145622.
Texto completo da fonteSu, Christopher T., Liying Chen, Jason Chen, Brian Parkin, Avery Polk, Malathi Kandarpa, Craig E. Cole et al. "Role of Aneuploidy in Transcriptional Regulation and Clinical Prognosis in Relapsed and/or Refractory Multiple Myeloma (RRMM)". Blood 136, Supplement 1 (5 de novembro de 2020): 45–46. http://dx.doi.org/10.1182/blood-2020-134558.
Texto completo da fonte